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Abstract: Purpose. To assess inflammatory involvement of cornea in dry eye by means of confocal microscopy, 
evaluating the presence and distribution of Langherans cells (LCs). 
Methods: 98 eyes of 49 subjects were enrolled: 18 subjects affected by Sjögren Syndrome Dry Eye (SSDE), 17 with  
Non-Sjögren Syndrome Dry Eye (NSSDE), 14 healthy volunteeers. Dry eye symptoms, tear film, ocular surface damage 
and corneal confocal microscopy were analized. 
Results: A significant increase of LCs density was observed at sub-basal nerve plexus (SSDE = 79 cells/mm2 and  
NDE = 22 cells/mm2; p = 0,0031) and sub-epithelial nerve plexus (SSDE = 38 cells/mm2 and NDE = 3 cells/mm2;  
p = 0,0169) in central cornea of SSDE group. An increased number of LCs from the center to the periphery of the cornea 
was observed, significant only in healthy volunteers group. In dry eye patients there was an increase in LCs density  
in both peripheral and central cornea with a significant difference between NDE (14,66 cells/mm2) and SSDE  
(56,66 cells/mm2) only in central cornea (p = 0,0028). In SSDE group, mean density of LCs in central cornea results also 
superior to NSSDE group (29,33 cells/mm2). 
There was no correlation between LCs density and dry eye symptoms, tear film deficiency and ocular surface damage. 
Conclusion: This study demonstrates the activation of an inflammatory and immunological reaction in cornea of NSSDE 
and SSDE patients. Confocal microscopy can be an important diagnostic tool in evaluation and follow-up of dry eye 
disease. 
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INTRODUCTION 
 Tear film deficiencies are among the most common eye 
problems [1]: epidemiologic studies have reported that more 
than 6% of the population over the age of 40 suffer from dry 
eye, with the prevalence increasing to 15% of the population 
over the age of 65 [2-4]. Using a prevalence of 6% and the 
2000 census data, there are an estimated 7.1 million people 
in the US over the age of 40 who experience dry eye 
symptoms. Most studies have found an increasing prevalence 
with age and some studies have shown a greater prevalence 
of dry eye among women [2, 4, 5]. 
 The 2007 International Dry Eye WorkShop (DEWS) [6] 
defined dry eye as a multifactorial disorder of the tear film 
and ocular surface that results in eye discomfort, visual 
disturbance, and often ocular surface damage, characterized  
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by hyperosmolarity of tear film and inflammation of ocular 
surface. 
 Rheumatologic diseases are often associated with 
ophthalmic findings, particularly ocular surface diseases and 
dry eye diseases. Sjögren syndrome (SS) is a multisystem 
autoimmune disease characterized by hypofunction of the 
salivary and lacrimal glands. It is among the group of 
diseases overseen by rheumatologists and its management 
requires 3 areas of specialty practice: rheumatology, 
ophthalmology and oral medicine. It is clear that SS is a a 
systemic, multiorgan autoimmune disease, that it has got a 
chronic or progressive course and that is characterized by 
secretory disfunction [7, 8]. The American College of 
Rheumatology [8] recently proposed a classification which 
applies to individuals with sign/symptoms that may be 
suggestive of SS. Particularly it is fundamental to have at 
least 2 of the following 3 objective features: 
1. Positive serum anti-SSA/Ro and/or anti-SSB/La or 
(positive rheumatoid factor and ANA titer ≥ 1:320) 
2. Labial salivary gland biopsy exhibiting focal 
lymphocytic sialadenitis with a focus score ≥ 1 
focus/4 mm2 
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3. Dry eye disease with keratoconjunctivitis sicca with 
ocular staining score > 3 (in individuals not using 
hypotensive eye drops for lowering intraocular 
pressure and in individuals that did not underwent 
corneal surgery or cosmetic eyelid surgery in the last 
5 years). 
 In the clinical evaluation of dry eye patients there is no 
actually established gold standard: several test are used in 
the clinical practice which analyze patient’s symptoms, tear 
production, tear quality, ocular surface damage. All of these 
diagnostic test have low sensibility and little reproducibility, 
in particularly in patients with severe dry eye [9]. 
 Tear film hyperosmolarity is recognized as an important 
pathogenetic factor in dry eye syndrome, but its use is 
currently limited due to the complexity in its measurement. 
 Purpose of this work is to evaluate the presence and 
distribution of Langherans cells (LCs) in cornea of dry eye 
patients by means of confocal microscopy, in order to 
demonstrate an inflammatory reaction. 
 Originally described by Engelmann in 1867 [10], 
dendritic cells (DCs) are antigen-presenting cells (APCs) of 
bone marrow origin: the current concept is that corneal 
epithelial DCs are identical to the immunologically active 
LCs of the epidermis. The distribution of LCs in the central 
cornea is an issue of ongoing discussion: some investigators 
have already shown the presence of LCs in patients with 
herpes keratitis [11], in contact lens wearers and in healthy 
volunteers [12, 13] by using confocal microscopy. 
 In dry eye disease, in vivo confocal microscopy has 
provided new information on the whole-ocular surface 
morphofunctional unit. It has also improved understanding 
of pathophysiologic mechanisms and helped in the 
assessment of prognosis and treatment [14]. 
 Furthermore, confocal microscopy allows quick, 
noninvasive, steady-state respectful examination of the 
ocular surface at cellular level to be performed and has 
potential to be used in the future as a biomarker and to 
contribute to optimize the tailored management of these 
diseases [15]. 
MATERIALS AND METHODS 
 This study was performed with the ethical standards laid 
down in the 1964 Declaration of Helsinki and its later 
amendments. 
 We consecutively enrolled 3 groups of subjects: 18 
patients affected by Sjögren Syndrome (SSDE, Sjögren 
Syndrome Dry Eye), 17 patients affected by Non Sjögren 
Sydrome Dry Eye (NSSDE) and 14 healthy volunteers 
(NDE, Non Dry Eye). 
 Inclusion criteria in the SSDE group were: 
− the diagnosis of Sjögren Sydrome according to the 
diagnostic criteria of SICCA consensus [8]. 
 Inclusion criteria in the NSSDE group were: 
− dry eye diagnosed by Schirmer’s test without 
anesthesia < 10 mm/5 minutes, symptoms and signs 
of dry eye, not recognized as Sjögren Sydrome. 
 Inclusion criteria in the normal control subjects group 
were: 
− Schirmer ‘s test without anesthesia > 10 mm/5 
minutes 
− FBUT (Fluorescein Break Up Time) > 10 seconds 
− absence of fluorescein and lissamine green staining. 
 Exclusion criteria in all groups included: 
− use of contact lenses 
− previous ocular trauma or surgery 
− drug allergies 
− systemic or ocular diseases except dry eye itself and 
evolving cataract 
− patients less than 18 years old 
− pregnant or nursing women 
− inability to understand and/or complete the OSDI 
questionnaire and the tests 
 Each subject, following detailed explanation and 
acquisition of informed verbal consent, was evaluated by this 
procedure: 
1. Ocular Surface Disease Index (OSDI) questionnaire 
2. slit lamp examination of lid and ocular surface 
3. tear meniscus height (TMH) assessment 
4. FBUT measurement 
5. Schirmer’s test without anesthesia 
6. Oxford Grading Scheme (OGS) evaluation of ocular 
surface fluorescein and Lissamine green staining 
7. corneal confocal microscopy with Heidelberg Retina 
Tomograph in combination with Rostock Cornea 
Module: a detachable system equipped with a water 
contact objective (63x/0.9 W, 670 nm, ∞/0; Zeiss, 
Jena, Germany). The device includes a contact system 
under a video control. The focus level was defined 
and changed in axial direction by both external 
manual and internal z-scan, generating images of the 
cornea with precise information on the depth of the 
analysis. The confocal microscopy was performed, 
after topical application of anesthesia (oxybuprocaine 
hydrochloride 0.4%) and a drop of carbomer gel 
(COMFORT® gel, Bausch & Lomb, Berlin, 
Germany) in the eye with the lowest Schirmer test for 
dry eye patients and in the eye with the higher 
Schirmer test in normal subjects, in two different 
corneal areas: central and peripheral at six o’clock. A 
total number of three sections (intermediate epithelial 
cells, sub-basal nervous plexus and sub-epithelial 
nervous plexus) in each studied area was examined: 
the number of LCs was counted manually in the 
largest ROI (maximum Region Of Interest: 0.1589 
mm2) per epithelial section by using a grid system 
with a 50-µm grid width and is given as cells per 
square millimetre. 
8. Intermediate epithelial cells section was defined [16] 
as the epithelial layer between the surface epithelium 
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cells (that have got light cells boundaries and bright 
visible nuclei) and basal epithelium cells (smaller 
cells with light cells boundaries and without visible 
nuclei). The sub-basal layer [17] was defined as the 
layer included between the basal epithelial layer 
(clearly demarcated with reflective cell borders to 
dark non-reflective cell bodies) and the Bowman 
layer (that appears as a transitional zone bordered by 
the basal epithelium and the anterior stroma, 
distinguished by brunching nerve fibres against an 
amorphous background). 
9. The sub-epithelial layer was defined as the anterior 
2/3 of the corneal stroma where the large nerve fibers 
enters [16]. 
Statistical Analysis 
 In 98 eyes of 49 subjects enrolled in the study only one 
eye in each patient was studied by confocal microscopy and 
used for statistical analysis: 
§ NDE group: the eye with the highest score at the 
Schirmer test 
§ SSDE and NSSDE groups: the eye with the lowest 
score at the Schirmer test 
 Differences between qualitative variables were tested 
using the chi-square test (Pearson) or the Fischer test. 
Differences between quantitative variables were studied 
using the variance analysis: for normally allocated data with 
t-test corrected according to Bonferroni for meaningful 
differences, for non-normally distributed data with the 
Kruskal-Wallis test or the Wilcoxon rank-sum (Mann-
Whitney) if the variance analysis was significant. 
 Correlation coefficients (between the number of LCs and 
OSDI, BUT, TMH, Schirmer test, OSG) were calculated 
with the Spearman test. 
RESULTS 
 All subjects examined in the study were women and there 
were not significant differences (p = 0.06) between their 
mean age. 
 Symptoms complained by subjects and evaluated by 
OSDI questionnaire were significantly or marginally 
significantly different between groups (SSDE versus NDE:  
p = 0.001; SSDE versus NSSDE: p = 0.052; NSSDE versus 
NDE: p = 0.054). Higher OSDI scores in the NSSDE and 
NDE group can be due to the excessive scatter of the index 
[18]. 
 Examination of ocular surface showed a significant 
incidence of blepharitis (p = 0.008) in eyes affected by dry eye 
compared to normal eyes (72.2% SSDE and 70.5% NSSDE), 
absence of lid keratinisation in normal subjects, significant 
prevalence of lacrimal meniscus irregularity (5.8% NSSDE and 
5.6% SSDE; p = 0.005) and conjunctival redness in dry eyes 
(58.8% NSSDE and 77.7% SSDE; p = 0.005). 
 Tears film evaluation showed significant reduction in 
TMH, BUT and Schirmer test values in dry eyes. 
 Ocular surface staining with fluorescein and Lissamine 
green showed a significant prevalence of epithelial damage, 
graded as the Oxford Grading Scheme (OGS), in subjects 
affected by dry eye (p = 0.001) (Table 1). 
 The number of LCs was counted manually in each 
corneal section: Table 2 gives the frequency of LCs in 
central and peripheral corneal sectors and the density of LCs 
in each corneal section. A significant increase of LCs density 
was observed at sub-basal nervous plexus (SSDE = 79 
cells/mm2 and NDE = 22 cells/mm2; p = 0.0031 - Wilcoxon 
rank-sum) and sub-epithelial nervous plexus (SSDE = 38 
cells/mm2 and NDE = 3 cells/mm2; p = 0.0169 - Wilcoxon 
rank-sum) in central cornea of patients affected by Sjögren 
Syndrome. 
 Table 2 gives also the mean values of LCs density 
calculated in central corneas and peripheral corneas of each 
group. There was a difference in LCs distribution: an 
increasing cell number from the center to the periphery of 
the cornea, but this trend difference between LCs density in 
these two corneal areas was significant only in normal 
subjects (NSSDE: p = 0.0605; SSDE: p = 0.4859; NDE:  
p = 0.0019 - Wilcoxon test). 
 There was not a significant difference between the 
gradient of LCs distribution (calculated from the difference 
of LCs density in central and peripheral corneas) in each 
group (p = 0.5093, Kruskal-Wallis test). 
 Essentially there was an increase in LCs corneal density 
in both the central and peripheral areas of dry eye patients, 
with a statistically significant difference between normal 
subjects (NDE = 14.66 cells/mm2) and dry eye patients with 
Sjögren Syndrome (SSDE = 56.66 cells/mm2) only in central 
sectors of the cornea (p = 0.0028 - Wilcoxon rank-sum). In 
SSDE group the mean value of density in central cornea 
resulted superior to NSSSDE group (NSSDE = 29.33 
cells/mm2). 
 No correlation was found (p > 0.05 - t test) between LCs 
density and dry eye symptoms (evaluated with OSDI), tear 
film deficiency and ocular surface damage (evaluated with 
FBUT, TMH, Schirmer’s test, staining with fluorescein and 
lissamine green). The correlation between OSDI and LCs 
density is displayed in Figs. (1, 2). 
DISCUSSION 
 We decided to analyze the intermediate corneal epithelial 
layers, particularly at the level of basal epithelial cells and 
sub-basal nerve plexus. It is well described [12] that LCs are 
located at depth of 35-60 µm, preferentially within the level 
of basal epithelial cells and sub-basal nerve plexus. This 
preferential localization of the LCs in the direct vicinity of 
nerve fibers or at least at the level of nerve bundles might be 
attributed to and explained by their usage of nerve plexus for 
intraepithelial movement [12]. 
 We could observe LCs corneal cells (with different 
frequency and density in the different examined corneal 
areas) in 47 patients out of 49 subjects (95%). In 2 patients 
affected by NSSDE we couldn’t find LCs. This percentage is 
much higher if compared to Zhivov et al. [12, 13] results in 
normal subjects (31.3%) and in contact lens wearers (59%). 
This could be partially explained by considering that Zhivov 
et al. [13] evaluated a different sample of patients: younger 
and more heterogeneous in sex distribution than our. 
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 Comparing our data to Zhivov et al. [12, 13] it seem that 
population examinated in the present study has got an higher 
frequency of cornea LCs, but a lower density of these cells. 
These Authors calculated an average density of LCs of 34±3 
cells/mm2 in central cornea and 98±8 cells/mm2 in peripheral 
cornea for the normal healthy volunteers and an average 
density of 78±25 cells/mm2 in central cornea and 210±24 
cells/mm2 in peripheral corneal of contact lens wearers. This 
difference can be explained by the fact that in our study we 
calculated the average values of LCs density observed in 
intermediate epithelial sectors, in sub-basal nerve plexus and 
in the sub-epithelial one (including areas where we didn’t 
observe LCs). In fact, if we consider the density of LCs in 
the sub-basal nerve plexus only, data of our study are more 
similar to Zhivov et al. [11]: NDE: 22 cell/mm2 versus  
82 cell/mm2; NSSDE: 44 cell/mm2 versus 88 cell/mm2; 
SSDE: 79 cell/mm2 versus 119.5 cell/mm2. 
 LCs were observed especially in the sub-basal nerve 
plexus in all groups (Table 2). Furthermore the density 
values of LCs seems to decrease from peripheral corneal to 
central corneal (Table 2). This gradient difference seems to 
reduce (even if without statistical significant p = 0.5) in NSSDE 
patients and particularly in SSDE patients, where the gradient is 
minimal (NDE: 14.66 cell/mm2 versus 44 cell/mm2; NSSDE: 
29.33 cell/mm2 versus 58.66 cell/mm2; SSDE: 56.66 cell/mm2 
versus 58.83 cell/mm2) (Fig. 3). 
Table 1. Population characteristics and clinical data. 
 
Population Characteristics and Clinical Data SSDE (n = 18) NSSDE (n = 17) NDE (n = 14) P Value 
Age 
Average age (years) 57.33 59.82 51.43 
0.06 
Range (years) 34-69 38-76 39-77 
OSDI Results 
Average score 53.84±20.49 36.71±23.55 18.56±15.99 SSDE vs NDE 0.0001 
SSDE vs NSSDE 0.052 
NSSDE vs NDE 0.054 Range 20.83-77.77 2.08-81.25 0-27.73 
Slit Lamp Examination (Number of Patients and %)  
Eyelid malpositions  0 (0%) 0 (0%) 0 
SSDE and NSSDE vs NDE 
>0.05 
Blepharitis 13 (72.22%) 12 (70.59%) 3 (21.43%) 
SSDE and NSSDE vs NDE 
0.008 
Lid keratinisation 4 (22.22%) 3 (17.65%) 0 
SSDE and NSSDE vs NDE 
0.196 
Lacrimal meniscus irregularity 1 (5.56%) 1 (5.88%) 10 (71.43%) 
SSDE and NSSDE vs NDE 
0.005 
Conjunctival redness 14 (77.78%) 10 (58.82%) 0 
SSDE and NSSDE vs NDE 
0.005 
Follicles ± papillae (conjunctival) 3 (16.67%) 2 (11.76%) 0 
SSDE and NSSDE vs NDE 
0.356 
Tear Film Evaluation 
TMH (in mm) average 0.13 0.19 0.28 SSDE and NSSDE vs NDE 
0.0001 TMH (in mm) standard deviation 0.07 0.07 0.05 
BUT (in seconds) median 3 4 11.5 SSDE and NSSDE vs NDE 
0.0001 BUT (in seconds) range 2-8 2-8 10-25 
Schirmer test (in mm) median 2.5 6 12.5 SSDE and NSSDE vs NDE 
0.0001 Schimer test (in mm) range 0-10 2-10 10-32 
Ocular Surface Staining Evaluation 
FOGS Average 2.22 1.47 0 SSDE and NSSDE vs NDE 
0.0001 FOGS Standard Deviation 1.16 1.00 0 
LGOGS Average 2.5 1.76 0 SSDE and NSSDE vs NDE 
0.0001 LGOGS Standard Deviation 1.09 1.09 0 
SSDE: Sjögren Syndrome Dry Eye, NSSDE: Non Sjögren Syndrome Dry Eye, NDE: Non Dry Eye; OSDI: Ocular Surface Disease Index; THM: Tear meniscus height; BUT: break 
up time; FOGS: Fluorescein Oxford Grading Scheme; LGOGS: Lissamine Green Oxford Grading Scheme. 
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 Considering the analysis in the different corneal sections, 
density of LCs is superior in the SSDE group if compared to 
NDE group at the sub-basal nerve plexus (SSDE:  
79 cell/mm2 versus NDE: 22 cell/mm2; p = 0.0031) and at 
sub-epithelial plexus (SSDE: 38 cell/mm2 versus NDE:  
3 cell/mm2; p = 0.0169). Difference between SSDE group 
and NSSDE group is significant only at sub-epithelial plexus 
(SSDE: 38 cell/mm2 versus NSSDE: 0 cell/mm2;  
p = 0.0109). 
 Comparing now the mean density values of LCs (average 
value calculated from the LCs density at the three different 
corneal sections) we can underline a significant difference 
between the NDE group and the SSDE group (SSDE:  
56.66 cell/mm2 versus NDE: 14.66 cell/mm2; p = 0.0028) 
and between the SSDE group and the NSSDE group (SSDE: 
56.66 cell/mm2 versus NSSDE: 29.33 cell/mm2; p = 0.0332) 
in the central corneal. We didn’t observe significant 
differences in the peripheral cornea. This is in agreement 
with previous studies [12, 13, 19] which demonstrated that in 
Table 2. Presence and distribution of Langherans Cells in different corneal sections and areas. 
 
Presence of LCs (% of Positivity of LCs) SSDE NSSDE NDE P Value 
Central cornea  
1 55.55 29.41 35.71  
2 100 88.23 92.85 
3 77.77 41.17 50 
Peripheral cornea 
1 66.66 35.29 57.14 
2 100 88.23 100 
3 83.33 47.05 64.28 
LCs Density in Each Corneal Section (Cell/mm2) 
Central cornea 
1 (median) 25 0 0 SSDE and NSSDE vs NDE 
 
0.0833 1 (range) 0-126 0-50 0-31 
2 (median) 79 44 22  
SSDE and NSSDE vs NDE 
0.0098 
 
SSDE vs NDE 0.0031 
2 (range) 13-371 0-392 0-63 
3 (median) 38 0 3 SSDE and NSSDE vs NDE 
0.0130 
 
SSDE vs NDE 0.0169 
3 (range) 0-201 0-76 0-44 
Peripheral cornea 
1 (median) 34,5 0 16 SSDE and NSSDE vs NDE 
0.2343 1 (range) 0-107 0-164 0-44 
2 (median) 119.5 88 82 SSDE and NSSDE vs NDE 
0.0791 2 (range) 25-398 0-541 6-258 
3 (median) 50 0 22 SSDE and NSSDE vs NDE 
0.0791 3 (range) 0-189 0-157 0-101 
Mean LCs Density in Each Corneal Area (Cell/mm2) 
Central cornea (median)  56.66 29.33 14.66 SSDE and NSSDE vs NDE 
 
0.0061 Central cornea (range)  4.33-165.33 0-130.66 0-42 
Peripheral cornea (median)  58.83 58.66 44 SSDE and NSSDE vs NDE 
0.1032 Peripheral cornea (range)  21-159.33 0-220 2-119.33 
  













1. Intermediate epithelial cell layers 
2. Sub-basal nerve plexus 
3. Sub-epithelial nerve plexus 
LCs: Langherans Cells; SSDE:Sjögren Syndrome Dry Eye; NSSDE: Non Sjögren Syndrome Dry Eye; NDE: Non Dry Eye. 
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the corneal limbal epithelium, dendritic cells are present in 
almost every healthy subject, while in the central cornea only 
20-30% of healthy controls show APCs. 
 Therefore, we found an increase in the Langherans cells 
number in the central corneal of dry eye patients. This 
increment is significant only in patients affected by Sjögren 
syndrome, that usually leads to a more severe keratocon-
junctivitis sicca. We didn’t observe a significant difference 
in LCs density values in the peripheral cornea of dry eye 
patients and normal patients. 
 Lin H et al. [20] recently investigated the morphology, 
distribution and density of inflammatory cells in the corneal 
epithelium of NSSDE, SSDE and healthy volunteers 
subjects, finding a significant correlation between LCs and 
leukocytes density and the severity of the clinical evaluation. 
The increased density of epithelial DCs observed by Lin may 
 
Fig. (1). Correlation between LCs density in central cornea and OSDI. 
 
Fig. (2). Correlation between LCs density in peripheral cornea and OSDI. 
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indicate - as our results - a heightened immune status of the 
cornea. 
 Marsovszky L. et al. [21] found a prevalence of central 
and peripheral LCs - together with central LCs morphology 
values - significantly higher than normal in patients affected 
by rheumatoid arthritis. This alteration of LCs in rheumatoid 
arthritis suggests an active inflammatory process in the 
cornea, which may reflect an increased activation state of the 
innate immune system, even in inactive stages of the disease 
and without ocular symptoms. 
 A recent research studied ocular surface inflammation in 
relation to systemic disease activity in rheumatoid arthritis 
(RA) patients with or without secondary Sjögren's syndrome 
(SSII and non-SSII respectively). Differences in the clinical, 
cellular and cytokine responsiveness to systemic RA 
treatments show that the ocular surface pathology is 
dissimilar for RA SSII and RA non-SSII patients [22]. 
 Little is known about the exact molecular mechanisms 
that regulating LC maturation in the cornea, or those keeping 
large numbers of these LCs in an immature state. Centripetal 
migration of LCs play a critical role in promoting 
immunoinflammatory responses in the eye, but the molecular 
mechanisms responsible for ocular LC migration are poorly 
understood [23], also because corneal tissue is avascular and 
without lymphatic support. 
 In the murine corneal epithelium after cauterization of 
the central cornea, a migration and maturation of resident 
LCs and expression of MHC II has been demonstrated, 
without expression of these molecule in peripheral cornea. 
Hamrah et al. [24] found that in inflammation, the 
expression of MHC class II and B7 molecules (CD80 and 
CD86) is potently upregulated. This upregulation was 
observed in cauterized corneas uniformly at day 3 after 
cauterization: first near the cautery sites and later throughout 
the cornea. Although cells migrating into the cornea from the 
limbus also contribute to the increased density of MHC class 
II+ and B7+ cells, data of this study suggest that most of these 
cells, especially in the central and paracentral areas, are 
resident LCs. 
 The concept of centripetal LCs migration is well 
described in literature. Some Authors [25] hypothized the 
“X,Y,Z theory”, considering “X” the proliferation of basal 
epithelial cells; “Y” the contribution to the cell mass by 
centripetal movement of peripheral cells; and “Z” the 
epithelial cell loss from the surface. The maintenance of 
corneal epithelium can be defined by the equation: “X + Y = 
Z”, which states that if the corneal epithelium is to be 
maintained, cell loss must be balanced by cell replacement. 
 Banchereau and Steinman [26] underlined that B and T 
lymphocytes are the mediators of immunity, but their 
function is under the control of dendritic cells. Dendritic 
cells in the periphery capture and process antigens, express 
lymphocyte co-stimulatory molecules, migrate to lymphoid 
organs and secrete cytokines to initiate immune responses. 
They not only activate lymphocytes, they also tolerize T 
cells to antigens that are innate to the body (self-antigens), 
thereby minimizing autoimmune reactions. We don’t know 
exactly what determines the direction and the movement of 
DCs. It is well known that cytokines and chemochines (i.e. 
GM-CSF, TNF-α and IL-1, MIP-1α and -β) can modulate 
movements [27, 28] and maturation of DCs. Among these 
IL-1 e TNF-α are more expressed in tear fluid and 
conjunctival citology of dry eye patients [29]. 
 Using in vivo confocal microscopy LCs appears as bright 
corpuscolar particles with different morphologies: individual 
cell bodies without processes, cells bearing dendrites or cells 
arranged in a network via long interdigitating dendrites. In 
Fig. (4) we can observe LCs with confocal microcopy in a 
SSDE patient (Fig. 4). 
 Langherans’ cells with dendritis are more frequently 
described in the peripheral cornea, while Langherans’cells 
without dendritis are described both in central and peripheral 
cornea, more frequently in central sectors. The central cornea 
is endowed with these cells that seems to be the immature 
and precursor DCs, both in the epithelium and the stroma, 
where in Langerhans cells and monocytic DC reside, 
respectively [16, 20, 30]. 
 In the present study we couldn’t observe a significant 
difference between the morphology of LCs in the central or 
in the peripheral corneal sectors. We could not appreciate 
any difference between the morphology of LCs in the central 
and in the peripheral cornea. Rather in each patient the 
 
Fig. (3). LCs gradient difference between central and peripheral cornea in NDE, NSSDE e SSDE patients. 
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morphology of the cells was typical: in some patients the 
cells had a dendritic morphology irrespective of the area 
investigated. 
 A correlation between LCs density and evaluation of 
signs and symptoms of dry eye can’t be established. 
Recently it has been reported that alterations in nerve cell 
morphology rather than density, toghether with an increase 
in APCs, can be responsible for the corneal mechanical 
hypersensitivity in SSDE patients [31]. 
 In conclusion this study, finding APCs corneal cells 
(LCs) using confocal microscopy, demonstrated the 
activation of an inflammatory and immunological reaction in 
cornea of dry eye patients (both NSSDE and SSDE patients). 
 Actually we don’t have a precise diagnostic test to assess 
the amount of inflammation in the ocular surface of dry eye 
patients to suggest a customized clinical approach. The 
increased density of APCs in the sub-basal and sub-epithelial 
layers is not present only in SSDE patients. Recently it has 
been reported in Meibomian gland disease also [32, 33], 
although in this group of patients as well as in NSSDE the 
density is significantly lower than in SSDE patients. 
 We believe that confocal microscopy can be an important 
diagnostic tool in the evaluation of dry eye disease, with 
possible therapeutical implications. The finding of an 
important inflammatory and immunological activation can 
suggest a different and more “aggressive” therapeutical 
protocol, with anti-inflammatories or corticosteroids or 
ciclosporine. Confocal microscopy might also prove useful 
in the follow-up of dry eye patients. 
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